• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Acyclovenir
    / BioAvenir


    Active Ingredient
    Acyclovir 250 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Vial

    5 X 250 mg / 10 ml

    not in the basket chart 40523 9596

    Dosage

    See prescribing information for full details.


    Indications

    Treatment of herpes simplex infections and severe initial genital herpes in the non-immunocompromised.Prophylaxis of herpes simplex infections in immunecompromised patients.Treatment of varicella zoster infections. Herpes simplex encephalitis.Treatment of herpes simplex infection in neonates and infants up to 3 months of age.


    Contra-Indications

    Known previous hypersensitivity to acyclovir or valacyclovir.


    Special Precautions

    The dose must be adjusted in patients with impaired renal function in order to avoid accumulation of acyclovir in the body. In patients receiving higher doses (e.g. for herpes encephalitis), specific care regarding renal function should be taken, particularly when patients are dehydrated or have any renal impairment. Pregnancy and lactation: Caution should be exercised by balancing the potential benefits of treatment against any possible hazard to the fetus. Caution is advised if administered to a nursing woman.
    See prescribing information for full details.


    Side Effects

    Inflammation or phlebitis at injection site, transient elevations of serum creatinine or BUN.
    See prescribing information for full details.


    Drug interactions

    No significant interations have been identified.
    See prescribing information for full details.


    Pregnancy and Lactation

    Caution should be exercised by balancing the potential benefits of treatment against any possible hazard to the fetus. Caution is advised if administered to a nursing woman.


    Manufacturer
    Reig Jofre SA, Spain
    Licence holder
    CLOSE